Intelligence Platform
Patents
Browse 991 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7115637
Inhibitors of p38
granted patentUS 7109215
Compounds possessing neuronal activity
granted patentUS 7109172
Inhibitors of serine proteases, particularly HCV NS3-NS4A protease
granted patentUS 7105546
Acyclic and cyclic amine derivatives
granted patentUS 7098330
Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors
granted patentUS 7091343
Compositions useful as inhibitors of protein kinases
granted patentUS 7087642
Inhibitors of IMPDH enzyme
granted patentUS 7087603
Pyrazole compounds useful as protein kinase inhibitors
granted patentUS 7084159
Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
granted patentUS 7078209
CAK inhibitors and uses thereof
granted patentUS 7074782
Carbamate caspase inhibitors and uses thereof
granted patentUS 7056944
Pyrazole compositions useful as inhibitors of erk
granted patentUS 7053057
Caspase inhibitors and uses thereof
granted patentUS 7041687
Indazole compounds useful as protein kinase inhibitors
expired patentUS 7008948
Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors
expired patentUS 6995261
4-pyridazinecarboxamides and esters as interleukin-1Ξ² converting enzyme inhibitors
expired patentUS 6995141
Interleukin 1Ξ² protease and interleukin 1Ξ² protease inhibitors
expired patentUS 6994868
Compositions useful as inhibitors of ERK
expired patentUS 6989385
Pyrazole compounds useful as protein kinase inhibitors
expired patentUS 6974809
Inhibitors of interleukin 1-Ξ² converting enzyme
expired patentUS 6967214
Inhibitors of IMPDH enzyme
expired patentUS 6962996
Inhibitors of p38
expired patentUS 6962936
Triazole-derived kinase inhibitors and uses thereof
expired patentUS 6949580
Pyrazole compositions useful as inhibitors of ERK
expired